What to do when cannabis gets admitted
|
|
- Cordelia Lewis
- 5 years ago
- Views:
Transcription
1 What to do when cannabis gets admitted I have nothing to disclose and no conflicts of interest or funding sources I will be discussing unapproved drugs and unapproved uses for drugs Kari L. Franson, PharmD, PhD, BCPP Associate Dean and Associate Professor Department of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences Objectives At the completion of this activity, the participant will be able to: 1. Guide patients & clinicians regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively 2. Describe the legal issues that arise when hospital patients are using cannabis lawfully under state laws
2 A provider asks What can you tell me about the diseases that medical marijuana has been approved for? Number of states with various approved medical conditions Alzheimer s disease (11) Epilepsy/seizures (29) Nausea (21) ALS (18) Glaucoma (27) Pain (25) Arthritis (3) Hepatitis C (12) Parkinson s disease (10) Cachexia (24) HIV/AIDS (28) Peripheral neuropathy (5) Cancer (28) Multiple sclerosis (15) PTSD (24) Crohn s disease (19) Muscle spasticity (22) Tourette s syndrome (4) Wong FH, Borgelt LA, Franson KL. Int Med Rev 2018 Tell me what you think I believe that patients gain the most benefit using medical cannabis for: A. Nausea and vomiting control B. Appetite stimulation C. Pain control D. Seizure control E. Feeling of euphoria
3 National Academies: Health Effects of Cannabis Conclusive or substantial evidence that cannabis or cannabinoids are effective: as anti-emetics in the treatment of chemotherapy-induced nausea and vomiting (oral cannabinoids) for treatment of chronic pain in adults (cannabis) for improving patient-reported multiple sclerosis (MS) spasticity symptoms, but limited evidence for clinicianmeasured spasticity (oral cannabinoids) National Academies of Sciences, Engineering, and Medicine The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press. doi: / National Academies: Health Effects of Cannabis Moderate evidence that cannabinoids, primarily nabiximols, are effective: to improve short-term sleep outcomes in patients with sleep disturbance associated with obstructive sleep apnea, fibromyalgia, chronic pain, and MS. National Academies of Sciences, Engineering, and Medicine The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press. doi: /24625.
4 National Academies: Health Effects of Cannabis Limited evidence that cannabis or oral cannabinoids are effective for: increasing appetite and decreasing weight loss associated with HIV/AIDS (cannabis and oral cannabinoids) improving symptoms of Tourette syndrome (THC capsules) improving anxiety symptoms in individuals with social anxiety (cannabidiol) improving symptoms of post-traumatic stress disorder (nabilone) better outcomes (i.e., mortality, disability) after a traumatic brain injury or intracranial hemorrhage statistical association National Academies of Sciences, Engineering, and Medicine The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press. doi: / National Academies: Health Effects of Cannabis Limited evidence that cannabis or oral cannabinoids are ineffective for: improving symptoms of dementia (cannabinoids) improving intraocular pressure associated with glaucoma (cannabinoids) reducing depressive symptoms in individuals with chronic pain or MS (nabiximols, dronabinol, and nabilone) National Academies of Sciences, Engineering, and Medicine The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press. doi: /24625.
5 National Academies: Health Effects of Cannabis No or insufficient evidence to support or refute that cannabinoids are effective for: cancer-associated anorexia cachexia syndrome and anorexia nervosa cancers, including glioma irritable bowel syndrome epilepsy spasticity in patients with paralysis due to spinal cord injury chorea and certain neuropsychiatric symptoms associated with Huntington s disease symptoms associated with amyotrophic lateral sclerosis (ALS) Parkinson s disease or levodopa-induced dyskinesia dystonia treatment for mental health outcomes in individuals with schizophrenia or schizophreniform psychosis achieving abstinence in the use of addictive substances National Academies of Sciences, Engineering, and Medicine The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press. doi: / Chemotherapy induced nausea and vomiting Small studies compared THC (dronabinol, nabilone) to dopamine antagonists Dronabinol showed anti-emetic efficacy over neuroleptics (but high risk of bias) NNT = 3.4 Depression (13%), hallucinations (6%), paranoid delusions (5%), occurred, but patients preferred cannabis over control (RR 0.33; 95% CI ) Smoking relief % vs. capsule relief 76-88% The standard of care for prevention of CINV for highly and moderately emetogenic chemotherapy is: 5-HT3 receptor antagonist, dexamethasone, aprepitant/fosaprepitant Tramer MR, Carroll D, Campbell FA, et. al. BMJ 2001; Musty RE, Rossi R J Cannabis Ther 2001; Todaro B. J Natl Compr Canc Netw Machado Rocha FC, Stefano SC, De Cassia Haiek R, et. al. Eur J Cancer Care 2008
6 Chronic (neuropathic and cancer) pain Review of trials with >30% reduction in pain 2 cancer pain trials 6 neuropathic pain trials Concluded moderate quality of evidence to support the use of cannabis for chronic pain Common analgesics for neuropathic pain *to achieve 30% reduction in pain Whiting PF, Wolff RF, Deshpande S, et al. JAMA 2015 Grant I. Report to the State of California 2010 Multiple sclerosis-associated spasticity American Academy of Neurology (AAN) evidence-based guideline recommendations Oral cannabis extract, synthetic THC, Sativex Several double-blinded RCTs > 1,000 patients Subjectively improved spasticity and pain Sativex also helped with urinary frequency Objective measures not significant Smoked cannabis Data inadequate to determine safety/efficacy Yadav V, Bever C, Bowen J, Bowling A, et. Al. Neurology 2014
7 Cachexia and appetite stimulation 8 controlled studies in AIDS- or cancer-related cachexia 3 studies of smoked marijuana (up to 67 patients) Others used dronabinol Non-statistically significant weight gain, increase appetite, and improve functional status Megestrol 750 mg weight gain > dronabinol 5 mg Combo did not lead to additional weight gain Cancer patient results were less consistent Abramovici H. Health Canada 2013 Timpone JG, Wright DJ, Li N, et. al. AIDS Res Hum Retro 1997 Post-Traumatic Stress Disorder A few RTC show improved symptoms Observational study >2200 Veterans from Never users, stoppers, continuing users and starters Adjusted for covariates of baseline symptoms, drug & alcohol use, violent behavior and employment Marijuana use associated with worsening of PTSD symptom severity, violent behavior, and alcohol & drug use Wilkinson ST, J Clin Psychiatry 2015
8 Seizures Uncontrolled case series in intractable childhoodonset epilepsy CBD : THC ratio 20 : 1 Median monthly seizure frequency Baseline 30.0 (interquartile range [IQR] ) After 12 week treatment 15.8 (IQR ) Some weaned patient from another AED after starting CBD Adults case reports and patient surveys Seizure exacerbation with discontinuation German study no effect Friedman D, Devinsky D, NEJM 2015 Gloss D, Vickery B. Cochrane Database Syst rev 2014 Glaucoma Systemic administration of cannabis IOP by 30% Pilot study of 6 patients IOP for 2 hours Uncontrolled study 9 patients with open-angle glaucoma THC qid IOP Patients appeared to develop tolerance, and all discontinued the study Flach AJ. Trans-American Ophthalmological Society 2012
9 Tell me what you think How would you respond to a 40 yo patient who asks you to help them use cannabis for cancer pain? The patient asks Are you worried I am going to get addicted? NIDA (
10 Lifetime dependency risk with use 100 % % MJ addiction risk in teens 23% 17% 15% 9% 0 Hall and Degenhardt. Lancet Strahny A. CBHSQ Report A mother asks Is cannabis going to fry my son s brain? Brain development in adolescence Limbic region Immediate rewards Impulsive behavior Cortex Long term gain Thoughtful behavior accessed 5/28/2013
11 Effect on neuropsychological functioning Persistent cannabis users show neuropsychological decline from childhood to midlife Prospective study of 1,037 individuals followed from birth (1972/1973) to 38 years of age Within-person IQs : Never used Used, never regularly Used regularly Impairment of learning, memory, and executive functions Meier MH, et al. Proc Natl Acad Sci Chronic cognitive effects of cannabis (A) Relation between amount of marijuana smoked 2 and Repetition of Numbers Task, number correct for the high Shipley IQ group (squares) and the low Shipley IQ group (circles). (B) Relation between amount of marijuana smoked 2 and performance on the Stroop task for the high Shipley IQ group (squares) and the low Shipley IQ group (circles) Bolla KI, et al. Neurology, 2002
12 Cannabis and psychosis Multiple studies have demonstrated an increased risk of psychosis in THC users 3 meta-analyses have shown an odds ratio of 1.4 to 2.9 Risk with cannabis use is up to 3 fold higher compared to those who did not use cannabis After control for a variety of confounding factors including other drug use and socioeconomic variables Pierre JM. Current Psychiatry The patient asks Are there other effects of cannabis besides in the brain? Potential AEs from chronic cannabis use Respiratory Increased sputum production, wheezing, bronchitis Potential increase in chronic bronchitis, emphysema, and airway inflammation Gastrointestinal Cannabinoid hyperemesis syndrome Genitourinary Increased risk of failing a drug test Reproductive Menstrual cycle disruption Decreased sperm count Impotence and decreased libido May decrease lactation Hematology/ Potential increased risk of nasopharyngeal carcinoma Oncology Potential for increased risk of lung cancer, however, data is inconclusive. Many products may contain other carcinogens. Cannabis smoke contains known carcinogens. Metabolic/Endocrine Potential to increase insulin resistance in adipose tissue 24
13 Acute cardiovascular effects of THC Heart rate HRV The variation in the time interval between heartbeats (RR-interval) HRV is a predictor of mortality after MI L Zuurman, et al. Br J Clinical Pharmacology Cannabis use and long-term mortality among survivors of AMI Kaplan-Meier estimates of post-mi survival among 87 cannabis users and 174 propensity-matched nonusers. Frost L, et al. American Heart Journal. 2013
14 Tell me what you think How would you respond to the patient who says no one has ever died from using cannabis? The patient asks I still want to try it How much should I take? THC dosing is known; but not known for other CBs Typical effective dosing of inhaled THC Low dose < 7 mg Medium dose = 7 18 mg High dose > 18 mg There is a known tolerance to THC down regulation of CB1 receptors, and G-protein activation High probability of tolerance with chronic use, and low with intermittent Chronic = daily for a week, intermittent = weekly L Zuurman, et al. Br J Clinical Pharmacology. 2008
15 A patient asks How often should I take it? PK profile of smoked THC Smoking cannabis turns ~50% of the THC content into smoke Up to 50% of inhaled smoke is exhaled again, and some undergoes localized metabolism in the lung Bioavailability of a inhaled dose of THC is between 10-25% Effects are perceptible within seconds and fully apparent in a few minutes Effects last about 3 hours Strougo A, et al. J Psychopharmacology PK profile of oral THC Onset of effect is delayed: 1-3 hours due to slow absorption from the gut Bioavailability of THC after oral ingestion ranges from 5-20% in the controlled environment of clinical studies Weight, metabolism, gender and eating habits play a role in absorption Effects last about 6 12 hours Agurell S, Halldin M, Lindgren JE, et al. Pharmacological reviews. 1986
16 PK profile of oromucosal THC/CBD - Sativex One study did not find difference between oral THC capsules and oromucosal spray PK Peak concentration THC 1.5 hours Peak concentration CBD 1.3 hours 2-fold inter-patient variability in peak THC and CBD levels Karschner EL, Clin Chem 2011 Further dosing considerations THC substrate of CYP3A4 & 2C9 CBD substrate of CYP3A4 & 2C19 Possible drug interactions sedation, ataxia: CNS depressants, anticholinergics heart rate: sympathomimetics effects of: hexobarbital, hydrocortisone, clozapine, phenytoin, warfarin effects of: propofol, indinavir, theophylline Horn JR, Pharmacy Times 2014
17 Vaporizing cannabis plant or concentrate Same immediate effects and benefits as smoking Heats F vaporizing CBs Conductive vs. convective heating Images from: ; Dabbing cannabis concentrates CBs are extracted by solvents Butane hash oil (BHO), dabs, earwax, butter or shatter >90% of CBs Superheat nail (with blow torch) and add dab Users quickly develop tolerance Images from:
18 Edible baked goods, candies, tinctures Edibles have CBs added, or are infused with CB butter, oil or alcohol Colorado 10mg serving size and 100mg maximum/package Doesn t release toxins Discreetly consumed Must exit dispensary in child resistant packaging Now also prohibit edibles that resemble animals, people or fruit Images from: Cannabis infused creams, lotions and oils THC not charged, but lipophilic properties limit it getting to site of action Most products claim no psychoactive effects, so THC not getting absorbed Patch with occlusion and vehicle to enhance absorption Images from:
19 So how can I help? C.R.S Unprofessional conduct - grounds for discipline 1) The board may suspend, revoke, refuse to renew, or otherwise discipline any license or registration. (c) Has violated: (III) Any state or federal law pertaining to drugs;
20 Institutions carry risk for allowing cannabis use Because they are accredited through the Center for Medicare & Medicaid Services, hospitals could be found to be in violation, lose federal funding, and face penalties The Joint Commission Standard MM policy states: The hospital safely controls medications brought into the hospital by patients, their families, or licensed independent practitioners. Borgelt LM & Franson KL. Hosp Pharm 2017,582(2): Accessed Dec Institutions carry risk for allowing cannabis use Joint Commission Standard MM includes the following elements of performance: The hospital defines when medications brought into the hospital can be administered Before use, the hospital identifies the medication and visually evaluates the medication s integrity The hospital informs the prescriber and patient if the medication brought into the hospital is not permitted Accessed Dec 2016.
21 Institutions carry risk for allowing cannabis use The Washington Health Care Association template (Accessed Aug 2016) Institutions carry risk for allowing cannabis use The institution may choose to access the cannabis product through the FDA s expanded access (compassionate use) program This program allows access for an individual patient or more widespread use when the disease state is serious and a sponsor is actively developing the product Accessed Aug 2016.
22 Tell me what you think I believe that patients are most likely to access cannabis at my institution by: A. Compassionate use processes B. Following Joint Commission Standard MM processes C. Changing law Review today s session Provided information for you to guide patients & clinicians regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively Described the legal issues that arise when hospital patients are using cannabis lawfully under state laws
Medical Cannabis. Kari L. Franson, PharmD, PhD, BCPP Associate Dean and Associate Professor Department of Clinical Pharmacy
Medical Cannabis Kari L. Franson, PharmD, PhD, BCPP Associate Dean and Associate Professor Department of Clinical Pharmacy Objectives Identify the main constituents of cannabis Review the endocannabinoid
More informationAct 16 and Medical Cannabis in Pennsylvania
Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health
More informationCANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE
1 CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations
More informationMedical vs Recreational Use of Cannabis. 11 th December 2017
1 Medical vs Recreational Use of Cannabis 11 th December 2017 2 Defining Cannabis and Chemical Constituents Cannabis is a plant species. Two main Cannabis sub-species are Cannabis Sativa and Cannabis Indica.
More informationJames McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada
James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into
More informationMedical Cannabis. Kari L. Franson, PharmD, PhD, BCPP Associate Dean for Professional Education
Medical Cannabis Kari L. Franson, PharmD, PhD, BCPP Associate Dean for Professional Education At the end of this activity, participants should be able to: 1) Identify the contents in cannabis that effect
More informationMEDICAL MARIJUANA: WHAT S THE EVIDENCE?
MEDICAL MARIJUANA: WHAT S THE EVIDENCE? L A U R A A. M A R K L E Y, M D B O A R D - C E R T I F I E D I N P E D I A T R I C S / G E N E R A L P S Y C H I A T R Y / C H I L D & A D O L E S C E N T P S Y
More informationDr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE
Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)
More informationMedical Marijuana Consent Form
Medical Marijuana Consent Form A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient or the patient s parent or legal
More informationThe Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy
The Effects known & unknown of Marijuana in Older Adults Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy Learning Objectives 1. Review various dosing strategies for medical
More informationMedical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More informationCurious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD
Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Speaker Disclosures We have/had no financial relationships with any commercial interests
More informationCannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017
Cannabis and What we Know Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 We All Have a Role to Play! Objectives What is Cannabis? What do we know about the health effects? Legalization:
More informationA summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids
A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids Background paper commissioned by the EMCDDA for the report Medical use of cannabis and cannabinoids:
More informationOutcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationEducating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C
Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will
More informationCannabis Use: Scope of the Issue
Three Areas of Focus How Changing Cannabis Policy Will Affect Your Practice Kevin P. Hill, MD, MHS Director, McLean Hospital Division of Alcohol and Drug Abuse Belmont, MA Assistant Professor of Psychiatry,
More informationThis questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.
Introduction This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level. Definition: The term "extracts and tinctures" refers to substances that
More informationUse of Cannabinoids in Medical Practice
Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced
More informationA look at Marijuana in 2014
A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5
More informationINITIAL PATIENT INTAKE FORM
INITIAL PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional use only.
More informationMedical Marijuana: Hype versus Evidence
Medical Marijuana: Hype versus Evidence Monica Malec, MD The University of Chicago, Department of Medicine Section of Geriatrics and Palliative Medicine Objectives Understand the requirements for physician
More information9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.
Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section Disclosures Site principal investigator of studies of cannabidiol(epidiolex) in the treatment of
More informationBudding Therapies: Medical Cannabis and its Uses
Budding Therapies: Medical Cannabis and its Uses MARIAH CADAVOS, PHARMD & VIVIAN NGUYEN, PHARMD PGY1 PHARMACY PRACTICE RESIDENTS FEBRUARY 10, 2019 1 Disclosures & Disclaimer Both presenters have nothing
More informationMedical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids
Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State
More informationMedical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids
Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State
More informationCBD and Your Health.
CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear
More informationMedicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer
Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabis Substantial public interest Legalised by the Qld Government Guidance
More informationMarijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US
Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest
More informationI would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people
I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid
More informationClinical Policy Title: Botanical marijuana for medical use
Clinical Policy Title: Botanical marijuana for medical use Clinical Policy Number: 00.02.10 Effective Date: January 1, 2015 Initial Review Date: August 20, 2014 Most Recent Review Date: October 19, 2017
More informationMedical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic
Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial
More informationAcknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making
Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response
More informationMARIJUANA in MEDICAL CARE READY or RISKY. HINDI MERMELSTEIN, MD FAPM Beth Israel Medical Center, NYC Dec
MARIJUANA in MEDICAL CARE READY or RISKY HINDI MERMELSTEIN, MD FAPM drhmermelstein @optimum.net Beth Israel Medical Center, NYC Dec 11 2015 HISTORY MARIJUANA (CANNABIS SAVITA) HAS LONG BEEN PART OF RELIGIOUS
More informationAGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up
AGENDA 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up Marijuana: Preventing Youth Use Juliet D Alessandro, Healthy Communities Specialist Today
More informationMedical Marijuana Update Chris Belletieri, DO
Dr. Belletieri has provided no disclosures. Graduated PCOM in 1996 In private practice since 1999 Board Certified in FP since 1999 Program Director of FP residency at Lower Bucks Hospital in Bristol, PA
More informationMedical Marijuana: The Move to Schedule II
Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions
More informationPATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:
PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: / / Gender: Male Female Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell: Email: Primary
More informationCANNABIS FOR THE RHEUMATOLOGIST
CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology
More informationUSING ALTERNATIVE MEDICATION: MEDICAL CANNABIS (MARIJUANA)--BENEFITS AND HARMFUL EFFECTS JENNIFER KAPUR, PHARM.D. MARCH 1, 2016
USING ALTERNATIVE MEDICATION: MEDICAL CANNABIS (MARIJUANA)--BENEFITS AND HARMFUL EFFECTS JENNIFER KAPUR, PHARM.D. MARCH 1, 2016 OBJECTIVES Compare and contrast federal law and state laws regarding marijuana
More informationMEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA MINNESOTA ACADEMY OF PHYSICIAN ASSISTANTS MARCH 18, 2016 TOM ARNESON, MD, MPH MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program
More informationDoc, will you sign my medical. Fellow in Hematology/Medical Oncology General Internal Medicine Grand Rounds
Doc, will you sign my medical marijuana card? Daniel W. Bowles, MD Fellow in Hematology/Medical Oncology General Internal Medicine i Grand Rounds September 21, 2010 Disclosures Skeptical about marijuana
More informationMedical Cannabis: A Patient Primer
Medical Cannabis: A Patient Primer This primer is meant for documented patients who are using medicinal cannabis or considering using it in the future. The information provided about this medication in
More informationNorthern California Chapter, ACP Update In Medicine
Northern California Chapter, ACP Update In Medicine Kathleen A. Kenny MD Clinical Associate Professor of Medicine Primary Care and Population Health November 3, 2018 UPDATE ON MARIJUANA Kathleen A. Kenny
More informationWelcome to MedWell. MedWell Health and Wellness Centers. Don t live with PAIN Live WELL MedWell. o Newspaper o Referred by.
1 Welcome to MedWell Patient Information Date: Name: Date of Birth: / / Address: City: State: Zip Code: Home Phone: ( ) - Cell Phone: ( ) - Email: Gender: o Male o Female State Drivers License: Social
More informationPOLICY NUMBER: POL 153
Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines
More informationMedicinal Marijuana: The Canadian Journey
Medicinal Marijuana: The Canadian Journey Nady el-guebaly MD Professor & Head, Addiction Division, UofC Research Director, Alberta Gambling Research Institute Chief Examiner, ISAM Certification Disclosures:
More informationMarijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine
Marijuana DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine Objectives Describe marijuana laws in the state of Oregon and the nation List evidence available for
More informationMedical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.
Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center Controversies in Pain Management Conference Johnson City, TN November 13, 2015 Disclosure
More informationCDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only
CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of
More informationMedical Marijuana in the Workforce. What This Is...And What It Isn t
Medical Marijuana in the Workforce Recommendations for the Occupational Physician Robert S. Goldsmith, M.D., M.P.H. June, 2014 What This Is...And What It Isn t IS: Historical context Legal and social context
More informationCannabis and cannabinoids for medicinal purposes
Cannabis and cannabinoids for medicinal purposes International Evidence and Evidence for Practice in Australia Michael Farrell Louisa Degenhardt, Wayne Hall, Nicholas Buckley, Megan Weir, Suzi Neilsen,
More informationMedical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator
Medical Cannabis Program Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator Disclaimer The following information is based upon research of current studies. The Department of Health
More informationMD GUIDE TO USING MEDICAL CANNABIS
Natural Remedy MD GUIDE TO USING MEDICAL CANNABIS The leaves and flowers of the Cannabis plant are consumed in several forms: dried flower buds or various types of concentrated, loose, or pressed resin
More informationThe Highs and Lows of Medical Marijuana
The Highs and Lows of Medical Marijuana Jill Vargo Cavalet, MHS, PA-C Marijuana use is prevalent worldwide yet remains controversial in health care. The general public often regards marijuana as a benign
More informationMedical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.
Medical Marijuana Questions from Part 1: 1. is a plant species, variety known as hemp. a. Cannabis sativa Linnaeus b. Cannabis sativa c. Cannabis indica d. Cannabis Lemark 2. The major psychoactive compound
More informationResearch on Cannabis and PD: Is there any evidence?
Research on Cannabis and PD: Is there any evidence? Benzi M. Kluger, MD, MS Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver DISCLOSURES
More informationMedicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system
Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the
More informationMarijuana. DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM
Marijuana DATE: June 26, 2018 PRESENTED BY: Melissa Weimer, DO, MCR, FASAM Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members of the planning committee
More informationReefer Madness version 3.0*
Reefer Madness version 3.0* Presenter Disclosure *Original Reefer Madness: FMF 2014 by R. Dubin, Sharon Cirone and Mel Kahan Update on Health Canada s MMPR and the use of cannabis for medical conditions
More informationThe Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association
The Sale of Cannabis in Pharmacies Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association Development This activity was developed by the American Pharmacists
More informationRequirement for Certification from a Health Care Practitioner. Requirement for Certification from a Health Care Practitioner
Johnson County Pharmacists Association Current Status of the Iowa Ronald A. Herman, Ph.D. 1 Objectives Identify the current status of Iowa medical cannabis regulations. List the current disease conditions
More informationClinical Policy Title: Botanical marijuana for medical use
Clinical Policy Title: Botanical marijuana for medical use Clinical Policy Number: CCP.1132 Effective Date: January 1, 2015 Initial Review Date: August 20, 2014 Most Recent Review Date: October 2, 2018
More informationClinical Policy Title: Botanical marijuana for medical use
Clinical Policy Title: Botanical marijuana for medical use Clinical Policy Number: 00.02.10 Effective Date: January 1, 2015 Initial Review Date: August 20, 2014 Most Recent Review Date: October 13, 2015
More informationMarijuana as Medicine
Marijuana as Medicine What is medical marijuana? The term medical marijuana refers to using the whole, unprocessed marijuana plant or its basic extracts to treat symptoms of illness and other conditions.
More informationThe Return of Medicinal Cannabis
The Return of Medicinal Cannabis George Kolodner, M.D. DLFAPA FASAM Chief Clinical Officer Clinical Professor of Psychiatry Georgetown University School of Medicine University of Maryland School of Medicine
More informationSusan Audino, PhD S.A. Audino & Associates, LLC
Cachexia, Cancer, Chronic Pain, Epilepsy, Glaucoma, HIV, AIDS, Multiple Sclerosis, Nausea, ALS, Crohn s, Hepatitis C, Anorexia, Arthritis, Migraine, Parkinson s, Damage to the Nervous Tissue of the Spinal
More informationMarijuana and the Chronic Non-Cancer Pain Patient
Marijuana and the Chronic Non-Cancer Pain Patient Kevin P. Hill, M.D., M.H.S. Pain 101: Provider Workshop 9/23/16 McLean Hospital Division of Alcohol and Drug Abuse khill@mclean.harvard.edu DrKevinHill.com,
More informationMEDICAL CANNABIS PATIENT COUNSELING. Krissy Bernazani, RPh Clinical Director Zen Leaf
MEDICAL CANNABIS PATIENT COUNSELING Krissy Bernazani, RPh Clinical Director Zen Leaf DISCLOSURE Krissy Bernazani is a paid employee of Freestate Wellness, dba Zen Leaf Maryland, a medical cannabis dispensary.
More informationMEDICAL CANNABIS IN MINNESOTA
MEDICAL CANNABIS IN MINNESOTA EPILEPSY & SEIZURES WELLNESS EXPO APRIL 16, 2016 MICHELLE LARSON, MPA MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program State
More informationLearning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages
Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD CECILIA HILLARD, PHD DEPARTMENT OF PHARMACOLOGY NEUROSCIENCE RESEARCH CENTER Disclosures Member of the Scientific Advisory Board
More informationMedical Marijuana Update: Evidence vs. Reality
Outline Medical Marijuana Update: Evidence vs. Reality Michael G. McDonell, PhD Associate Professor, Elson S Floyd College of Medicine Chair, Committee for Cannabis Research and Outreach mmcdonell@wsu.edu
More informationHealth Impact of Cannabis: Adolescents
Health Impact of Cannabis: Adolescents Leslie R. Walker-Harding, MD National Academies committee on the Health Effects of Marijuana Meeting August 18, 2016 THC on the Human Brain NIDA Cannabis/Marijuana
More informationPennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum
Pennsylvania House of Representatives Joint Health and Judiciary Committee Hearing Medical Cannabis - Health Care Forum Tuesday, March 24, 2015 Philadelphia, Pennsylvania Testimony offered by: David J.
More informationCoalition for Medical Marijuana Research & Education
Coalition for Medical Marijuana Research & Education Nagi Kumar, Ph.D., R.D., FADA Professor, Oncologic Sciences Director, Cancer Chemoprevention Executive Director, Coalition for Medical Marijuana Research
More informationConflicts of interest
David Casarett MD MA Professor of Medicine Chief of Palliative Care Duke University Conflicts of interest SAB: Curio Wellness, Gram Research, Resolve Digital, Clinicann Senior advisor: Silver Swan Capital
More informationIn New York State. Highly Worth It OR Not??? Medical Marijuana. The Truths 3/29/2018. True or False???
Medical Marijuana In New York State Highly Worth It OR Not??? Medical Marijuana True or False??? 1. Providers write prescriptions for medical marijuana true or false 2. Medical marijuana in NYS gives people
More informationMinnesota Medical Cannabis Program. October 24, 2017
Minnesota Medical Cannabis Program October 24, 2017 Agenda: Overview of Minnesota Medical Cannabis Program Conditions, roles, products Laboratory Issues Program Evaluation * indicates a hyper-link to website
More informationDr. Meldon Kahan. Women s College Hospital. with PIA LAW
with PIA LAW and Toronto ABI Network Dr. Meldon Kahan Women s College Hospital Dr. Meldon Kahan is an Associate Professor in the Department of Family Medicine at University of Toronto, and Medical Director
More informationObjectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access
Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology
More informationMarilyn is a 68 year old woman with breast cancer metastatic to the lungs and the thoracic and lumbar spine.
Alan M. Ehrlich MD Assistant Professor in Family Medicine University of Massachusetts Medical School June 18, 2014 Marilyn is a 68 year old woman with breast cancer metastatic to the lungs and the thoracic
More informationThe Shifting Federal Regulation of Cannabis Products
The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW
More informationMedical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015
Medical Marijuana Kent W. Peterson, MD, FACOEM Occupational Health Strategies, Inc. Charlottesville, VA Speaker Disclosure Requirements 1. Do not dispense, prescribe, refer or recommend MMJ 2. Have no
More informationLegalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine
Legalized Marijuana: Uses, Misuses & Abuses Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Disclosures Research grants McNeil Consumer Healthcare (Acetaminophen) Rare Disease Therapeutics
More informationMedical Marijuana. Navigating Medical Marijuana in Workers Compensation
Medical Marijuana Navigating Medical Marijuana in Workers Compensation Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers
More informationPATIENT QUESTIONNAIRE
PATIENT QUESTIONNAIRE Personal Information Date Name Date of Birth Age Height Weight Gender: Male / Female Address City State / Zip Home Phone Cell phone Work phone E-mail address Do you currently have
More informationOhio s Medical Marijuana Control Program
Ohio s Medical Marijuana Control Program Timeline September 8, 2016 House Bill 523 Effective November 5, 2016 Deadline for first Medical Marijuana Advisory Committee meeting May 6, 2017 Cultivator rules
More informationQuestionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction
Introduction This is one of five questionnaires that Member States are invited to complete ahead of the 40th WHO Expert Committee on Drug Dependence. This questionnaire will ask you about cannabis plant
More informationMedicinal Cannabis Dosage Forms in California
Mica Gross President Sante Botanica / COO MDBioLogics Medicinal Cannabis Dosage Forms in California An Overview of Cannabis Dosage Forms Forms of dosage are the specific vehicles by which cannabis, or
More information4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION
THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION Susan R Davidson, MD Maternal Fetal Medicine Department of Ob/Gyn St. Mary s Hospital Madison, WI SSM Health I HAVE NO FINANCIAL DISCLOSURES TO REPORT
More informationThe Cannabis model in Canada and the USA. Dr Mark A Ware MD MRCP MSc McGill University Montreal, Quebec, Canada
The Cannabis model in Canada and the USA Dr Mark A Ware MD MRCP MSc McGill University Montreal, Quebec, Canada Outline Canada Cannabinoid medicines Existing regulatory framework Proposed new regulations
More informationCAPC/CPNP Coalition Face to Face Meeting October 18, 2018
CAPC/CPNP Coalition Face to Face Meeting October 18, 2018 Topics What is cannabis and how is it used? What does the evidence say about health effects? What about effects during pregnancy and breastfeeding?
More informationDESCRIPTION DURATION
NAME DESCRIPTION DURATION 5 Basic Cannabis Questions Answered - Leafly 412 5 Differences Between Eating and Smoking Cannabis - Leafly 351 5 Things You Didn't Know About MMJ - Civilized 0 A Short History
More informationWorkplace Issues Associated with Legalized Marijuana. James B. Yates, Esq., SHRM-SCP, SPHR
Workplace Issues Associated with Legalized Marijuana James B. Yates, Esq., SHRM-SCP, SPHR jbyates@eastmansmith.com Agenda: Nationwide legalization efforts Ohio s medical marijuana law The impact of medical
More informationThe subject of marijuana in medical discourse has long
Medical Marijuana: Composition, Neurological Benefits, And Adverse Events This second in a two-part feature series on marijuana addresses the potential benefits of medical marijuana in neurology and considers
More informationGuidance for the use of. medicinal cannabis. in Australia. Patient information
Guidance for the use of medicinal cannabis in Australia Patient information Version 1, December 2017 Copyright Commonwealth of Australia 2017 This work is copyright. You may reproduce the whole or part
More informationMedical Cannabinoids for the Management of Chronic Noncancer Pain
Medical Cannabinoids for the Management of Chronic Noncancer Pain Dr Mark A. Ware MBBS MSc McGill University 12 June 2018 Disclosures Grants: CanniMed Consulting: CHI Inc Emmes 1 Canadian Consortium for
More information